175 related articles for article (PubMed ID: 12106493)
21. [Osteoporosis and bone morphogenetic protein (BMP)].
Higuchi C; Nakase T
Nihon Rinsho; 2005 Oct; 63 Suppl 10():439-43. PubMed ID: 16279679
[No Abstract] [Full Text] [Related]
22. [Development of BMP-related drugs].
Kawate H; Ohnaka K; Takayanagi R
Nihon Rinsho; 2005 Oct; 63 Suppl 10():463-6. PubMed ID: 16279683
[No Abstract] [Full Text] [Related]
23. Statin-induced osteogenesis uses in orthodontics: a scientific review.
Wong RW; Rabie AB
World J Orthod; 2006; 7(1):35-40. PubMed ID: 16548304
[TBL] [Abstract][Full Text] [Related]
24. [Stimulation of bone formation by anti-hyperlipidemic agent statins and its mechanism of action].
Yoneda T
Nihon Rinsho; 2002 Mar; 60 Suppl 3():688-95. PubMed ID: 11979970
[No Abstract] [Full Text] [Related]
25. Statins and bone morphogenetic proteins: new pathways in bone formation.
Edwards CJ
Ann Acad Med Singap; 2002 Mar; 31(2):245-7. PubMed ID: 11957568
[TBL] [Abstract][Full Text] [Related]
26. Statins and bone formation.
Garrett IR; Gutierrez G; Mundy GR
Curr Pharm Des; 2001 May; 7(8):715-36. PubMed ID: 11405194
[TBL] [Abstract][Full Text] [Related]
27. Mevalonate-suppressive dietary isoprenoids for bone health.
Mo H; Yeganehjoo H; Shah A; Mo WK; Soelaiman IN; Shen CL
J Nutr Biochem; 2012 Dec; 23(12):1543-51. PubMed ID: 22981371
[TBL] [Abstract][Full Text] [Related]
28. Piceatannol stimulates osteoblast differentiation that may be mediated by increased bone morphogenetic protein-2 production.
Chang JK; Hsu YL; Teng IC; Kuo PL
Eur J Pharmacol; 2006 Dec; 551(1-3):1-9. PubMed ID: 17026990
[TBL] [Abstract][Full Text] [Related]
29. The nucleocytoplasmic shuttling protein CIZ reduces adult bone mass by inhibiting bone morphogenetic protein-induced bone formation.
Morinobu M; Nakamoto T; Hino K; Tsuji K; Shen ZJ; Nakashima K; Nifuji A; Yamamoto H; Hirai H; Noda M
J Exp Med; 2005 Mar; 201(6):961-70. PubMed ID: 15781586
[TBL] [Abstract][Full Text] [Related]
30. Statins and osteoporosis: new role for old drugs.
Jadhav SB; Jain GK
J Pharm Pharmacol; 2006 Jan; 58(1):3-18. PubMed ID: 16393459
[TBL] [Abstract][Full Text] [Related]
31. Early healing pattern of statin-induced osteogenesis.
Wong RW; Rabie AB
Br J Oral Maxillofac Surg; 2005 Feb; 43(1):46-50. PubMed ID: 15620774
[TBL] [Abstract][Full Text] [Related]
32. A comparison between the effects of hydrophobic and hydrophilic statins on osteoclast function in vitro and ovariectomy-induced bone loss in vivo.
Hughes A; Rogers MJ; Idris AI; Crockett JC
Calcif Tissue Int; 2007 Nov; 81(5):403-13. PubMed ID: 17982704
[TBL] [Abstract][Full Text] [Related]
33. Compactin enhances osteogenesis in murine embryonic stem cells.
Phillips BW; Belmonte N; Vernochet C; Ailhaud G; Dani C
Biochem Biophys Res Commun; 2001 Jun; 284(2):478-84. PubMed ID: 11394905
[TBL] [Abstract][Full Text] [Related]
34. Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model.
Zhu W; Rawlins BA; Boachie-Adjei O; Myers ER; Arimizu J; Choi E; Lieberman JR; Crystal RG; Hidaka C
J Bone Miner Res; 2004 Dec; 19(12):2021-32. PubMed ID: 15537446
[TBL] [Abstract][Full Text] [Related]
35. Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells.
Sugiyama M; Kodama T; Konishi K; Abe K; Asami S; Oikawa S
Biochem Biophys Res Commun; 2000 May; 271(3):688-92. PubMed ID: 10814523
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts.
Tang CH; Yang RS; Chien MY; Chen CC; Fu WM
Eur J Pharmacol; 2008 Jan; 579(1-3):40-9. PubMed ID: 17980360
[TBL] [Abstract][Full Text] [Related]
37. Osteoblasts in osteoporosis: past, emerging, and future anabolic targets.
Marie PJ; Kassem M
Eur J Endocrinol; 2011 Jul; 165(1):1-10. PubMed ID: 21543379
[TBL] [Abstract][Full Text] [Related]
38. [Statin and bone metabolism].
Osuga J
Clin Calcium; 2004 Feb; 14(2):235-40. PubMed ID: 15576978
[TBL] [Abstract][Full Text] [Related]
39. HMG-CoA reductase inhibitors in osteoporosis: do they reduce the risk of fracture?
Schlienger RG; Meier CR
Drugs Aging; 2003; 20(5):321-36. PubMed ID: 12696993
[TBL] [Abstract][Full Text] [Related]
40. Fluvastatin and lovastatin but not pravastatin induce neuroglial differentiation in human mesenchymal stem cells.
Lee OK; Ko YC; Kuo TK; Chou SH; Li HJ; Chen WM; Chen TH; Su Y
J Cell Biochem; 2004 Nov; 93(5):917-28. PubMed ID: 15389871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
